Guo Wei-Yi, An Xiu-Ping, Sun Li-Jun, Dong Hong-Rui, Cheng Wen-Rong, Ye Nan, Wang Guo-Qin, Xu Xiao-Yi, Zhao Zhi-Rui, Cheng Hong
Renal Division, Department of Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Front Med (Lausanne). 2022 Aug 3;9:945913. doi: 10.3389/fmed.2022.945913. eCollection 2022.
IgA nephropathy (IgAN) encompasses a wide range of clinical and histology features. Some patients present without hematuria, with or without hypertension, still rapidly progress in renal function. Renal pathology of this part of patients were predominant intrarenal arteriolar lesions, rarely presented glomerular proliferative lesions. We aim to investigate the clinical and pathological characteristics and prognosis of these IgAN patients and initially explore whether the abnormal activation of complement is involved in the intrarenal arteriolar lesions of IgAN.
A total of 866 patients with renal biopsy-proven IgAN diagnosed at Beijing Anzhen Hospital were recruited. IgAN patients without intrarenal arteriolar lesions and proliferative lesions were excluded ( = 115), the rest were divided into arteriolar lesions group ( = 202) and proliferative lesions group ( = 549). Among them, 255 patients were regularly followed up for at least 1 year. Renal biopsy tissues of 104 IgAN patients were stained for complement components by immunohistochemistry and immunofluorescence.
Compared with proliferative lesions group, the arteriolar lesions group experienced high percentage of hypertension ( = 0.004), low percentage of gross hematuria ( = 0.001), microscopic hematuria ( < 0.001) and less initial proteinuria ( = 0.033). Renal survival between the two groups was not significantly different ( = 0.133). MBL, C4d, FH and FHR5, C3c, and MAC deposited on intrarenal arteriole in arteriolar lesions group. Compare with the proliferative lesion group, the arteriolar lesions group exhibited a higher intensity of C3c deposition on the intrarenal arterioles ( = 0.048). C3c and CD31 co-deposited on intrarenal arterioles area in patients with intrarenal arteriolar lesions.
Renal survival of the IgAN patients in arteriolar lesions group was not better than those in proliferative lesions group. Abnormal activation of complement may be involved in the pathogenesis of arteriolar damage through the injury of endothelial cells in this clinical phenotype of IgAN.
IgA 肾病(IgAN)涵盖广泛的临床和组织学特征。一些患者无血尿,伴或不伴高血压,但肾功能仍快速进展。这部分患者的肾脏病理以肾内小动脉病变为主,肾小球增殖性病变少见。我们旨在研究这些 IgA 肾病患者的临床和病理特征及预后,并初步探讨补体异常激活是否参与 IgA 肾病肾内小动脉病变。
共纳入 866 例在北京安贞医院经肾活检确诊的 IgA 肾病患者。排除无肾内小动脉病变和增殖性病变的 IgA 肾病患者(n = 115),其余患者分为小动脉病变组(n = 202)和增殖性病变组(n = 549)。其中 255 例患者进行了至少 1 年的定期随访。对 104 例 IgA 肾病患者的肾活检组织进行免疫组化和免疫荧光染色以检测补体成分。
与增殖性病变组相比,小动脉病变组高血压发生率高(P = 0.004),肉眼血尿发生率低(P = 0.001)、镜下血尿发生率低(P < 0.001)且初始蛋白尿少(P = 0.033)。两组的肾脏生存率无显著差异(P = 0.133)。MBL、C4d、FH 和 FHR5、C3c 以及 MAC 沉积于小动脉病变组的肾内小动脉。与增殖性病变组相比,小动脉病变组肾内小动脉上 C3c 的沉积强度更高(P = 0.048)。C3c 和 CD31 共沉积于有肾内小动脉病变患者的肾内小动脉区域。
小动脉病变组 IgA 肾病患者的肾脏生存率并不优于增殖性病变组。补体异常激活可能通过损伤 IgA 肾病这一临床表型的内皮细胞参与小动脉损伤的发病机制。